Multiple sclerosis (MS), a progressive disease of the brain and spinal cord, affects millions globally, including 93,500 Canadians. With one of the highest existing global MS rates, the number of Canadians living with MS is expected to increase to 133,600 by 2031 and the economic burden to reach $2 billion by the same date. Treatments […]
Read More